Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LHL Helse is a prominent Norwegian healthcare organization focused on the treatment and rehabilitation of patients with heart and lung diseases. Formerly the operational division of the National Association for Heart and Lung Diseases (LHL), the company manages specialized facilities including the LHL Hospital at Gardermoen and various regional rehabilitation centers. Its clinical expertise spans cardiac surgery, pulmonary rehabilitation, and the management of chronic conditions such as COPD and asthma. In late 2023, LHL Helse was acquired by Norlandia Health & Care Group, a move intended to integrate its specialized medical services into a broader Nordic healthcare network. The organization continues to operate as a vital private partner to the Norwegian public health sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LHL Helse.